表紙
市場調査レポート

医療向け3Dプリンティングの世界市場 2016年〜2026年:動向・研究開発・収益予測 - 歯科製品・医療用インプラント・医薬品・バイオプリンティング

3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026: Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing

発行 Visiongain Ltd 商品コード 293827
出版日 ページ情報 英文 245 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=135.00円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
医療向け3Dプリンティングの世界市場 2016年〜2026年:動向・研究開発・収益予測 - 歯科製品・医療用インプラント・医薬品・バイオプリンティング 3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026: Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing
出版日: 2016年02月17日 ページ情報: 英文 245 Pages
概要

世界の医療向け多次元プリンター技術市場は、2020年に28億5,400万米ドルを生成すると予測されています。

当レポートは、世界の医療向け3Dプリンティング市場における現状と見通しについて調査分析し、市場全体、部門別の収益予測、主要国市場の分析、専門家による見解、およびSWOT・STEP分析などを提供しており、主要企業のプロファイルを交えてお届けいたします。

第1章 レポート概要

第2章 医療産業向け3Dプリンティング:イントロダクション

  • 3Dプリンティング
  • バイオプリンティング:生体細胞のプリンティング
  • 医薬品の3Dプリンティング
  • 医療装置の分類

第3章 医療産業向け3Dプリンティング市場

  • 医療向け3Dプリンティング市場の現状
  • 医療産業における3Dプリンティング製品:2次市場の内訳
  • 世界の医療向け3Dプリンティング市場予測
  • 産業の促進因子・阻害因子
  • 医療向け3Dプリンティング収益予測:技術/製品別
  • 医療向け3Dプリンティング製品収益予測:2次市場

第4章 主要国の医療向け3Dプリンティング市場

  • 主要国の医療向け3Dプリンティング市場:実績および予測
  • 米国は予測期間を通して支配的市場地位を占める見込み
  • EU5ヶ国は2016年に市場の30%を占めるが、この数字は予測期間中にどう変化するか?
  • 日本:2017年に中国に次いで2番目のシェアを占める見込み
  • BRIC 諸国:安定して成長する見込み
  • ロシアは景気後退で今後5年間は厳しい状況となる見通し
  • ブラジル:歯科市場における急成長が3Dプリンティングへの機会を示す
  • インド市場は初期段階にある
  • その他の地域でも急速に成長中

第5章 医療向け3Dプリンティング:市場の主要企業

  • 業界の主要企業
  • 医療インプラント/歯科製品部門
  • バイオプリンティング部門
  • バイオプリンティングが商用化されるのはいつか?
  • 医療向け3Dプリンティング:2015年は医療業界にとって重要な転換期となったか?

第6章 医療産業向け3Dプリンティング:R&Dパイプライン

  • 医療インプラントの領域におけるR&D
  • バイオプリンティングの領域におけるR&D
  • その他の領域におけるR&D

第7章 医療向け3Dプリンティング産業の定性分析

  • 強みと弱み
  • 機会と脅威
  • STEP 分析:社会的、技術的、経済的および政治的影響要因

第8章 調査インタビュー

第9章 結論

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0090

Three dimensional printing for medicine - your new guide to trends, opportunities and sales potentials

What is the future of fabricating objects from digital models with 3D printers? Visiongain's new report gives you that data and analysis, letting you explore developments, technology and revenue predictions for uses in healthcare industries.

Our investigation forecasts those revenues to 2026 at overall world market, submarket and national level. Avoid falling behind in knowledge, missing opportunities or losing influence. Instead see what the future holds for additive manufacturing and find the potential gains.

Advances in 3D printing for medicine - find where that printer technology heads

With our updated study you explore the commercial prospects of those computer controlled industrial robots. See outlooks for medical devices, tissues, drugs and other applications.

That way you find potentials for those production tools for creating shapes and patterns as multiform designs. See how those advances can benefit medicine.

Those technologies hold crucial opportunities. So read on to explore that industry and see what its future market could be worth.

image1

Forecasts to 2026 and other information to help you stay ahead in knowledge

Besides revenue forecasting to 2026, our new work shows you recent results, sales growth rates and market shares. You also explore R&D and leading companies. Our study gives 56 tables, 58 charts and seven interviews with other authorities.

Information to help your work and save time, benefiting your influence

Is finding data on novel prototyping and production systems for healthcare proving a challenge? Now make your work easier, also saving time. Discover what the future holds for that emerging technology you cannot afford to ignore.

That way you help yourself stay ahead in knowledge, benefiting your analyses, decisions, authority and reputation for insight.

image2

Forecasting of that world market and its main segments - what is likely to happen?

What are the secrets of 3D printing's progress? What is the potential of that chemistry, engineering and biotechnology for healthcare? Discover in our report overall world revenue to 2026 for those synthetic processes for medical applications.

Also find individual revenue predictions to 2026 for six submarkets at world level:

  • Products - with sub-forecasts for dental products, medical implants, bio-printed tissue and other applications
  • Technology - processes for supporting those developments.

Which operations and processes will generate most money from 2016? With our investigation you assess outlooks for revenue growth, seeing where you can gain.

Our analysis helps you identify potential in that synthesis for medicine, producing complex geometries and surfaces. Explore the best revenue-generating applications.

Also see how that emerging industry gives opportunities from 2016 in developed and developing countries.

image3

National markets - where will highest revenues and fastest business expansion occur?

Needs for medical devices, diagnostics and pharmaceuticals worldwide expand use of manufacturing technologies using 3D print methods. In our investigation you examine the scope of three-dimensional printing.

Our analysis shows you individual revenue forecasts to 2026 for 11 countries:

  • United States (US)
  • Japan
  • Germany, France, UK, Italy and Spain (EU5 countries)
  • Brazil, Russia, India and China (BRIC group).

In our work you find regions with highest revenues, demand and sales potentials for that production. You discover international prospects, appraising needs and demands.

So explore how technology for multidimensional printing can benefit its developers, producers, marketers, sellers and users from 2016. Our work shows you, discussing trends, prospects and issues.

Events and forces for developing, producing, marketing and selling

The report explains forces affecting that industry and market, including these trends:

  • Technologies including selective laser sintering (SLS), direct metal laser sintering (DMLS), electron beam melting (EBM), stereolithography (SLA) and selective laser melting (SLM)
  • Bio-printed tissues, cells and compounds, including pharmaceuticals
  • Medical models, surgical guides and prototypes
  • Orthopaedic and cranio-maxillofacial implants and other medical devices.

You also see how these issues affect that industry and its users:

  • Regulatory requirements - abridged pathways, innovations and challenges with 3D technologies and materials
  • Replicating vascular tissue - a challenge restraining the bio-printing of replacement organs
  • Intervertebral discs, bioengineering, skin grafts, implantable cartilage, blood vessels, heart, lung, liver, bone and reconstructive surgery
  • Other advances in research and development, including improving biocompatibility and enhancing usefulness of the 3-dimensional constructs.

In our study you explore economic, political, social and technological questions, investigating outlooks for business. Examine what stimulates and restrains that industry and market. You hear what success is possible and see how you can gain.

Companies and overall 2020 market value - how high can 3D shaping revenues go?

What does the future hold? Our report predicts the world market for those multidimensional printer technologies for health will generate $2854 million in 2020, with further multiplication of revenue to 2026. Discover what is possible.

From 2016, healthcare corporations and specialty providers of that chemical and engineering technology can prosper. You discover how, why and when progress can occur. See what is possible.

You assess activities, progress and outlooks of organisations including these:

  • Stratasys
  • 3D Systems
  • EOS
  • Tissue Regeneration Systems
  • Oxford Performance Materials
  • Tronrud Engineering
  • Arcam AB
  • Organovo
  • Bio3D Technologies
  • Aprecia Pharmaceuticals Company.

In our study you also discover seven interviews with authorities in the field - technology firms and other organisations. That way you find what companies and other innovators say, think and do, helping you stay ahead in knowledge.

6 Ways 3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026 helps you

In these six main ways, our new study benefits your research, plans, decisions and presentations:

  • Revenues to 2026 at world level and for 6 submarkets - see outlooks for that emerging industry, its technology, marketing and sales
  • Forecasts to 2026 for 11 national markets in the Americas, Europe and Asia - investigate leading countries for potential revenues and expansion
  • Prospects for companies and other organisations - assess portfolios, progress, advantages, business strategies and developmental activities
  • Discussions of R&D - explore progress in that industry, finding technological, clinical and commercial opportunities and outlooks
  • Analysis of what stimulates and restrains that market - assess challenges and strengths, helping you compete and gain advantages
  • Interviews with 7 authorities in that field - researchers and companies - discover news and views to help you stay ahead and succeed.

That analysis, by our in-house team in the UK, gives knowledge to benefit your research, plans, decisions and proposals. It shows data you find nowhere else.

Knowledge found only in our work, helping your research, analyses and plans

Our report gives independent analysis. There you receive business intelligence found only in our work, finding where progress and money lie. With that knowledge you explore possibilities, helping you stay ahead and succeed.

With our updated and expanded investigation you are less likely to fall behind in information or miss opportunity. Find out how you could save time and effort. Also benefit your decisions and authority on that emerging, rising technology.

Trying our analysis now lets you explore 3D printing opportunities and predictions

Our new study is for everyone investigating 3D production techniques, equipment and devices for healthcare. In it you find revenue forecasting to 2026, with trends, analysis, data and discussions. Avoid missing out - please get our report here now.

Table of Contents

1. Report Overview

  • 1.1 Overview of 3D Printing for Healthcare: R&D, Industry and Market 2016-2026
  • 1.2 Why You Should Read This Report
  • 1.3 How This Report Delivers
  • 1.4 Main Questions Answered by This Analytical Report
  • 1.5 Who is This Report For?
  • 1.6 Methods of Research and Analysis
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to the 3D Printing for the Healthcare Industry

  • 2.1 3D Printing
    • 2.1.1 Stereolithography - The First 3D Printing Method
    • 2.1.2 Selective Laser Sintering (SLS), Direct Metal Laser Sintering (DMLS) and Selective Laser Melting (SLM)
    • 2.1.3 Electron Beam Melting (EBM)
  • 2.2 Bio-printing Organic Living Cells
    • 2.2.1 Approaches to Bio-printing
    • 2.2.2 Applications for Bio-printing
  • 2.3 3D Printing Pharmaceuticals
  • 2.4 Classifying Medical Devices
    • 2.4.1 The US Medical Devices Classification System
    • 2.4.2 The EU Medical Device Classification System

3. The 3D Printing Healthcare Global Market 2016-2026

  • 3.1 The Current State of the 3D Printing for Healthcare Market
  • 3.2 3D Printed Products in the Healthcare Industry: Submarket Breakdown
    • 3.2.1 Dental Product Submarket is still the Current Majority Market Share Holder
  • 3.3 Global Forecast for the 3D Printed Market 2016-2026
  • 3.4 Drivers and Restraints for the Global 3D Printed Healthcare Market
    • 3.4.1 Drivers of the Global 3D Printed Healthcare Market
    • 3.4.2 Restraints for the 3D Printed Healthcare Market
  • 3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast
    • 3.5.1 Technology: Revenue Forecast 2016-2026
    • 3.5.2 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket
    • 3.5.3 Products Revenue Forecast 2016-2026
    • 3.5.4 Drivers and Restraints for the 3D Printed Healthcare Products Submarket
  • 3.6 The 3D Printing Market for Healthcare: Product Submarket Revenue Forecasts 2016-2026
    • 3.6.1 Dental Products: Revenue Forecast 2016-2026
    • 3.6.2 Medical Implants: Revenue Forecast 2016-2026
      • 3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
      • 3.6.2.2 Drivers and Restraints for the 3D Printed Medical Implants, 2016
      • 3.6.2.3 FDA Approvals for 3D Printed Medical Implants
    • 3.6.3 Bio-printed Tissue: Revenue Forecast 2016-2026
    • 3.6.4 Bio-printed Tissue: Commercial Uses
      • 3.6.4.1 Bio-printed Liver Tissue: Preclinical Drug Testing
      • 3.6.4.2 Bio-printed Skin: Opportunities in Cosmetics and Burn Victims
      • 3.6.4.3 Bio-printed Cartilage: Facial Disfigurements and Knee Replacements
    • 3.6.5 Other Applications: Revenue Forecast 2016-2026
      • 3.6.5.1 3D Printed Surgical Tools: Accurate yet Expensive
      • 3.6.5.2 3D Printed Medical Modelling
      • 3.6.5.3 3D Printed Pharmaceuticals: 2015 Sees the First FDA Approval
      • 3.6.5.4 3D Printing to Help Combat Cancer

4. Leading National Markets for 3D Printing in Healthcare 2016-2026

  • 4.1 Leading National Markets for 3D Printing in Healthcare, 2016
  • 4.2 Leading National Markets for 3D Printing in Healthcare, 2020
  • 4.3 Leading National Markets for 3D Printing in Healthcare, 2026
  • 4.4 The US will be the Dominant Market in 3D Printed Healthcare for the Duration of the Forecast
    • 4.4.1 America Makes: A 'National Accelerator' for US 3D Printed Products
    • 4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
  • 4.5 The EU5 Will Account for almost third of the Market in 2016; How Will This Change over the Coming 10 years?
    • 4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
    • 4.5.2 France Demonstrates Strong Growth but a Deceasing Market Share
    • 4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
    • 4.5.4 Italian Orthopaedic Manufacturers are Prominent Consumers of AM Technology
    • 4.5.5 Spain has the Smallest 3D Printing for Healthcare Market in the EU5
  • 4.6 Japan Will be Overtaken as the Second Largest Market by China in 2017
  • 4.7 The BRIC Nations Show Strong Growth from 2020-2026
    • 4.7.1 China: Domestic Innovation is Keeping Pace with the West
      • 4.7.1.1 Chinese Market Restraints to 3D Printing for Healthcare
  • 4.8 Russian Recession Creates Challenges from 2015-2019
  • 4.9 Brazil's Rapidly Growing Dental Market Presents Opportunities for 3D Printing
  • 4.10 The Indian Market is in its Infancy
  • 4.11 The Rest of The World Market is Fast Growing

5. Market Leading Organisations

  • 5.1 Market Leaders in Technology: Hardware and Software
    • 5.1.1 Stratasys: Activities and Outlooks
      • 5.1.1.1 Growth Strategies for Stratasys
    • 5.1.2 3D Systems: Achievements and Activities
    • 5.1.3 EOS: A Market Leader in the Technology Submarket
    • 5.1.4 Autodesk Within: Autodesk Acquires Within Technologies
    • 5.1.5 Renishaw: UK-based 3D Printer Manufacturer
  • 5.2 Market Leaders in the Medical Implant/Dental Product Submarkets
    • 5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
    • 5.2.2 Oxford Performance Materials: Innovators with FDA Approvals to Match
    • 5.2.3 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
    • 5.2.4 Tronrud Engineering: A Provider
    • 5.2.5 Aortica: Abdominal Aortic Aneurysm Specialists
    • 5.2.6 Proto Labs Acquires Alphaform AG
    • 5.2.7 3T RPD Ltd: A Large Contributor to the U.K. National Market
    • 5.2.8 Arcam AB: Acquisitions Give Coverage of the Entire Production Line
    • 5.2.9 Xilloc Medical: Patient-Specific Implants from Design to Production.
    • 5.2.10 Fripp Design and Research: Commercial Products in the Pipeline
    • 5.2.11 Materialise NV: A Global Software and Printing Services Provider
    • 5.2.12 4WEB Medical: Strong Growth with More in the Pipeline
    • 5.2.13 Replica 3dm: Offering Medical Models for the NHS
    • 5.2.14 Zdravprint: 3D Printed Casts
  • 5.3 Leading Organisations in the 3D Bio-printing Submarket
    • 5.3.1 Organovo: the First Bio-printed Tissue on the Market
      • 5.3.1.1 Organovo exVive 3D Bio-printed Liver Tissue
      • 5.3.1.2 Organovo: 3D Printed Kidney Tissue in the Pipeline
    • 5.3.2 RegenHU: Creating 3D Bio-printers and Bioinks
    • 5.3.3 Bio 3D Technologies: The World's First Modular Bio-printer
    • 5.3.4 Osteopore International: Two FDA Approved Products
    • 5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
    • 5.3.6 Dentca
    • 5.3.7 Rainbow Biosciences: Bio-printing based on Magnetic Nanoparticles
    • 5.3.8 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
    • 5.3.8.1 Bio-printed Tissue for Drug Development
  • 5.4 When will Bio-printing be Commercially Available?
  • 5.5 3D Printed Pharmaceuticals: Was 2015 a Watershed Year for the Pharmaceutical Industry?
    • 5.5.1 Aprecia Pharmaceuticals Receives FDA Approval for Spritam, the First of a Kind
    • 5.5.2 The Cronin Group, University of Glasgow: Research into 3D Printing Pharmaceuticals
    • 5.5.3 FabRx: Changing the Shape of Drugs

6. 3D Printing for the Healthcare Industry: The R&D Pipeline

  • 6.1 The Pipeline for 3D Printed Medical Implants
    • 6.1.1 3D Printed Tracheal Splints
    • 6.1.2 Improving Biocompatibility of 3D Printed Medical Implants
      • 6.1.2.1 Vitamin B2 Can Improve Biocompatibility of 3D Printed Medical Implants
      • 6.1.2.2 Silicone is a Biocompatible Material Which Can be Used to Encase Implants
    • 6.1.3 3D Printing for Spinal Implants
      • 6.1.3.1 3D Printed Titanium Spinal Implants
      • 6.1.3.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
      • 6.1.3.3 3D Printing to Help Treat Babies With Spina Bifida
    • 6.1.4 Printing a Bionic Eye
  • 6.2 The Pipeline for 3D Printed Bioengineering
    • 6.2.1 3D Printing Human Skin
    • 6.2.2 3D Printing Cartilage: Research Making Commercial Availability Tangible
    • 6.2.3 3D Printing Vascular Tissue is a Complex Challenge Restraining the Bio-printing of Entire Organs
      • 6.2.3.1 Revotek: Creating a Blood Vessel Printer
      • 6.2.3.2 Bio-ink Research at Harvard University
      • 6.2.3.3 3D Printed Thryroid Gland - the First 3D Printed Organ?
      • 6.2.3.4 Sugar and Silicone Casted Blood Vessels
      • 6.2.3.5 The Artivasc 3D Project at the Fraunhofer Institute
    • 6.2.4 3D Printing to Fabricate Artificial Heart Valves
    • 6.2.5 3D Printing of the Nipple Areola Complex Graft for Reconstructive Surgery
    • 6.2.6 3D Printing Stem Cells
  • 6.3 The Pipeline for Other 3D Printed Healthcare Applications
    • 6.3.1 Eyedrivomatic: A 3D Printed Wheelchair
    • 6.3.2 3D Printed Pharmaceuticals: Changing Dose, Shape and API
      • 6.3.2.1 3D Printed Polypill for Cardiovascular Disease
      • 6.3.2.2 3D Printing New Active Pharmaceutical Ingredients
      • 6.3.2.3 Aprecia Have Three Products in their Pipeline
      • 6.3.2.4 Bringing Pharmaceuticals to Lesser Economically Developed Countries
    • 6.3.3 3D Printed Microbots for Healthcare

7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2016-2026

  • 7.1 Strengths of the 3D Printing for Healthcare Industry
    • 7.1.1 Growth Rates Are High - 3D Printing Holds Great Potential
    • 7.1.2 Demand for Customised Products is Increasing
    • 7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs Incurred on Health Systems
    • 7.1.4 More Efficient Use of Economic Resources in Manufacturing
    • 7.1.5 3D Printing Produces Complex Shapes and Parts
    • 7.1.6 3D Printing Technology is Advancing Rapidly
  • 7.2 Weaknesses of the 3D Printing for Healthcare Industry
    • 7.2.1 3D Printing is Expensive Technology
    • 7.2.2 Traditional Economies of Scale Cannot Yet be Achieved with AM
    • 7.2.3 AM is a New Technology which Requires Fewer Workers and New Expertise
    • 7.2.4 Access to Technology and Expertise is Currently Limited
    • 7.2.5 New Legislation will be Enforced Which Could Slow Advances
  • 7.3 Opportunities for the 3D Printing for Healthcare Market, 2016-2026
    • 7.3.1 Governments are Funding 3D Printing R&D Projects
    • 7.3.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
    • 7.3.3 New Applications for 3D Printing Technology are Being Developed
    • 7.3.4 Post-Production Finishing Will Require New Expertise
  • 7.4 Threats to the 3D Printing for Healthcare Industry, 2016-2026
    • 7.4.1 Regulatory Guidelines Must be Clarified
    • 7.4.2 A Media Coverage May Lead to An Investment Bubble
    • 7.4.3 High Volume Manufacturing is More Economical Using Traditional Methods
    • 7.4.4 There May be Unknown Side Effects Harmful to Health
  • 7.5 A STEP Analysis of the 3D Printing for Healthcare Market
  • 7.6 Social Influences on the 3D Printing for Healthcare Market
  • 7.7 Technological Influences on Market Trends
  • 7.8 Economic Influences on the Market
  • 7.9 Political Influences on the Market

8. Research Interviews

  • 8.1 Interview with Dr Stephen Hilton, UCL School of Pharmacy, FabRx, 3D Synthesis
    • 8.1.1 On 3D Printing Research at UCL, FabRx and 3D Synthesis
    • 8.1.2 On the Use of Hardware and Software
    • 8.1.3 On Commercial Ambitions for FAbRx
    • 8.1.4 On the Benefits and Barriers to 3D Printing in Healthcare
  • 8.2 Interview with Evan Youngstrom, Venture Counsel, Wilson Sonsini Goodrich & Rosati Professional Corporation
    • 8.2.1 On Intellectual Property Challenges
    • 8.2.2 On the Different Challenges Between Implants and Pharmaceuticals
    • 8.2.3 On the First FDA Approved 3D Printed Drug
  • 8.3 Interview with Peter Leys, Executive Chairman, Materialise N.V
    • 8.3.1 On the Beginning of Materialise N.V.
    • 8.3.2 On the Medical Products and Services Offered by Materialise N.V.
    • 8.3.3 On Materialise's Most Lucrative Products and Markets in 2015 and Beyond
    • 8.3.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
    • 8.3.5 On the Prospects of Materialise N.V. Over the Forecast Period
  • 8.4 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
    • 8.4.1 On the Application for 3D Bio-printing
    • 8.4.2 On the Commercial Prospects of the Technology
    • 8.4.3 On the Potential Factors That Could Inhibit Development
    • 8.4.4 On their Newly Released exVive 3D Liver Human Tissue
    • 8.4.5 On the Future of Organovo and the 3D Bio-printing Industry
  • 8.5 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
    • 8.5.1 On the Background of TRS
    • 8.5.2 On TRS' Portfolio
    • 8.5.3 On Their Commercialization Strategy
    • 8.5.4 Future
  • 8.6 Interview with Matthew Sherry, Managing Director, Replica 3dm
    • 8.6.1 On the History Behind Replica 3dm
    • 8.6.2 On Their Services and R&D Pipeline
    • 8.6.3 On Replica 3DM's Growth Plans
    • 8.6.4 On the 3D Printing for Healthcare Industry
  • 8.7 Interview with Lee Cronin, Regius Chair of Chemistry, University of Glasgow
    • 8.7.1 On the Cronin Group's 3D Printed Technology
    • 8.7.2 On Commercialisation Opportunities for Their Technology

9. Conclusions from Our Study

  • 9.1 The Overall 3D Printing for Healthcare Market can be Broken Down into Technology and Products
  • 9.2 Revenue for 3D Printed Healthcare Product Submarkets 2016-2026
  • 9.3 Leading National Markets for 3D Printing in the Healthcare Industry 2016-2026
  • 9.4 Market Trends for 3D Printing in Healthcare 2016-2026
    • 9.4.1 Centralised Organisations will Foster Growth
    • 9.4.2 Opportunities in Technology Development and Raw Material Production
    • 9.4.3 Increased Demand for Personalised Products is leading to Greater Penetration of Technology
    • 9.4.4 3D Printing is Most Established in the Product Submarket of Dentistry
    • 9.4.5 2015 Was a Landmark Year for the 3D Printed Pharmaceuticals
    • 9.4.6 Bio-printing Will Start to Bring in Commercial Revenue Within the Forecast Period
    • 9.4.7 Concluding Remarks

List of Tables

  • Table 1.1 Leading National Market Forecasts ($m): AGRs (%), Market Shares (%) and CAGRs (%) for 3D Printing in Healthcare, 2015-2026
  • Table 2.1 The US Classification of Medical Devices
  • Table 2.2 The EU Classification of Medical Devices
  • Table 3.1 Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2015
  • Table 3.2 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%), 2015, 2020 and 2026
  • Table 3.3 3D Printing for Healthcare: Global Market Forecast ($m), 2016-2026
  • Table 3.4 3D Printing Technology and Products for Healthcare: Market Share (%) and Market Size ($m), 2020
  • Table 3.5 3D Printing Technology and Products for Healthcare: Market Share (%) and Market Size ($m), 2026
  • Table 3.6 3D Printing Technology for Healthcare: Revenue Forecasts ($m), 2016-2026
  • Table 3.7 3D Printing Products for Healthcare: Revenue Forecast ($m), 2016-2026
  • Table 3.8 3D Printed Products for Healthcare by Submarket: Revenue ($m) and Market Share (%) Forecasts, 2016-2026
  • Table 3.9 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2015
  • Table 3.10 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2020
  • Table 3.11 3D Printing for Healthcare Product Submarket Revenue ($m) and Market Shares (%), 2026
  • Table 3.12 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2016-2026
  • Table 3.13 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2016-2026
  • Table 3.14 Bio-printed Tissue: Revenue ($m) and Market Share (%) Forecast, 2016-2026
  • Table 3.15 Other Applications: Revenue ($m) and Market Share (%) Forecast, 2016-2026
  • Table 4.1 Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2016, 2020, 2026
  • Table 4.2 Leading National Markets ($m) and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2020
  • Table 4.3 Leading National Markets ($m) and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2026
  • Table 4.4 Leading National Markets: Revenue Forecasts ($m), AGRs (%), Market Shares (%) and CAGRs (%) for 3D Printing in Healthcare, 2015-2026
  • Table 4.5 US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2016-2026
  • Table 4.6 EU5 National Markets ($m) for 3D Printing for Healthcare Forecast, 2016-2026
  • Table 4.7 German National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.8 French National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.9 UK National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.10 Italian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.11 Spanish National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.12 Japanese National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.13 Chinese National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.14 Russian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.15 Brazilian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.16 Indian National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 4.17 RoW National Market Forecast ($m): 3D Printing for Healthcare, 2016-2026
  • Table 5.1 Market Leading Organisations in the 3D Printing for Healthcare Market, 2016
  • Table 5.2 Stratasys Acquisition History
  • Table 5.3 3D Systems Healthcare-Related Acquisition History, 2012-2014
  • Table 5.4 Medical Implants Designed Using Within Technologies' Software
  • Table 5.5 Renishaw Overall Revenue ($m) and Revenue from Healthcare ($m), 2011-2016
  • Table 5.6 Oxford Performance Materials' Products to Receive FDA 510(K) Clearance
  • Table 5.7 Raw Materials Supplied by EOS and Used by C&A Tools for 3D Printed Products
  • Table 5.8 Arcam AB Actual Net Sales and Net Sales of Implants (2010-2014) and Forecasted Net Sales and Net Sales of Implants (2015-16)
  • Table 5.9 Leading Organisations in 3D Bio-printing, 2016
  • Table 5.10 EnvisionTEC 3D Printing Systems Available for the Medical and Dental Industries, 2016
  • Table 5.11 Prominent Organisations in the 3D Printed Pharmaceutical Industry, 2016
  • Table 6.1 Pipeline Areas and Locations of Research for 3D Printed Medical Implants, 2016
  • Table 6.2 Pipeline Areas and Locations of Research for 3D Printed Bioengineered Products, 2016
  • Table 6.3 Wake Forest Institute for Regenerative Medicine Research Areas, 2016
  • Table 6.4 Pipeline Areas and Locations of Research for Other 3D Printed Healthcare Applications, 2016
  • Table 7.1 Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2016
  • Table 7.2 Opportunities and Threats for the 3D Printing Industry for Healthcare, 2016-2026
  • Table 7.3 Platinum Member of America Makes, 2016
  • Table 7.4 Public Partners of America Makes, 2016
  • Table 7.5 Technological Improvements on 3D Printing Systems, 2016
  • Table 7.6 Technological Improvements on 3D Printing Software, 2016
  • Table 7.7 Technological Improvements on 3D Printing Raw Materials, 2016

List of Figures

  • Figure 1.1 Breakdown of the 3D Printing for Healthcare Market, 2016
  • Figure 3.1 Breakdown of the Market by Manufacturing Technology and Products, 2015
  • Figure 3.2 3D Printed Products for Healthcare by Application Market Share (%), 2015
  • Figure 3.3 Global Revenue Forecast for the 3D printed Healthcare Market, 2016-2026
  • Figure 3.4 3D Printing in the Healthcare Industry: Annual Growth Rates, 2016-2026
  • Figure 3.5 Drivers and Restraints of the 3D Printing for Healthcare Industry, 2016
  • Figure 3.6 3D Printing Technology and Products for Healthcare: Market Share (%), 2020
  • Figure 3.7 3D Printing Technology and Products for Healthcare: Market Share (%), 2026
  • Figure 3.8 Technology Revenue Forecast for the 3D Printed Healthcare Market, 2016-2026
  • Figure 3.9 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket, 2016
  • Figure 3.10 Product Revenue ($m) Forecast for the 3D printed Healthcare Market, 2016-2026
  • Figure 3.11 Product AGR (%) Forecast for the 3D printed Healthcare Market, 2016-2026
  • Figure 3.12 Drivers and Restraints for the 3D Printed Healthcare Product Submarkets, 2016
  • Figure 3.13 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2016-2026
  • Figure 3.14 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2015
  • Figure 3.15 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2020
  • Figure 3.16 3D Printing for Healthcare Product Submarket Revenue Shares (%), 2026
  • Figure 3.17 Drivers and Restraints of the 3D Printed Dental Product Submarket, 2016
  • Figure 3.18 Drivers and Restraints on the 3D Printed Medical Implants Submarket, 2016
  • Figure 3.19 Drivers and Restraints for 3D Printed Surgical Guides and Medical Modelling Market, 2016
  • Figure 3.20 Drivers and Restraints for the 3D Printed Pharmaceutical Market, 2016
  • Figure 4.1 Leading National Markets and Market Shares for 3D Printing Technology and Products for Healthcare, 2016
  • Figure 4.2 Leading National Markets and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2020
  • Figure 4.3 Leading National Markets and Market Shares (%) for 3D Printing Technology and Products for Healthcare, 2026
  • Figure 4.4 The US: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.5 The US: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.6 The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2016
  • Figure 4.7 Revenue Forecasts ($m) for EU5 3D Printing for Healthcare National Markets, 2016-2026
  • Figure 4.8 Germany: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.9 Germany: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.10 France: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.11 France: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.12 The UK: 3D Printing Market for Healthcare: Revenue Forecast ($m), 2016-2026
  • Figure 4.13 The UK: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.14 Italy: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.15 Italy: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.16 Spain: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.17 Spain: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.18 Japan: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.19 Japan: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.20 China: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.21 China: 3D Printing Market for Healthcare: AGR Forecast (%), 2016-2026
  • Figure 4.22 Russia: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.23 Russia: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.24 Brazil: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.25 Brazil: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.26 India: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.27 India: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 4.28 RoW: 3D Printing Market for Healthcare Revenue Forecast ($m), 2016-2026
  • Figure 4.29 RoW: 3D Printing Market for Healthcare AGR Forecast (%), 2016-2026
  • Figure 5.1 Renishaw Healthcare Revenue ($m) 2011-2016.
  • Figure 5.2 Breakdown of Arcam AB's Sales by Application, 2014
  • Figure 5.3 Arcam AB Actual Net Sales and Net Sales of Implants (2010-2014) and Forecasted Net Sales and Net Sales of Implants (2015-16)
  • Figure 6.1 Recipients and Deaths from Those on the Kidney Transplant Waiting List in The US, 2014
  • Figure 7.1 STEP Analysis of the 3D Printing for Healthcare Industry, 2016-2026
  • Figure 9.1 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Down Into Technology and Products, 2016-2026
  • Figure 9.2 Printed Products for the Healthcare Industry by Submarket: Comparisons of Revenue ($m), 2015, 2020 and 2026
  • Figure 9.3 Leading National Markets in the 3D Printing Industry for Healthcare: Market Shares in 2016, 2020, 2026

Companies Listed

  • 3D Bioprinting Solutions
  • 3D Synthesis
  • 3D Systems
  • 3T RPD
  • 4WEB Medical
  • 5N Plus
  • Air Force Research Laboratory
  • Adler Ortho
  • Alphaform AG
  • America Makes
  • American Cancer Society
  • Anatomics
  • Andiamo
  • ANSYS
  • Aortica
  • AP&C
  • Aprecia Pharmaceuticals
  • Arcam AB
  • Armed Forces Institute for Regenerative Medicine
  • Artivasc 3D
  • Asian Manufacturing Association
  • Autodesk
  • Autodesk Within
  • B3KD
  • Beijing AKEC
  • BestinClass SA
  • Bio 3D Technologies
  • Biomet
  • Bionics Institute
  • Blohm Jung
  • Boeing Company
  • Bonassar Research Group
  • C&A Tool
  • CalRAM
  • Canon
  • Chinese Food and Drug Administration
  • Chinese Ministry of Science and Technology
  • Clemson University
  • Commonwealth Scientific and Industrial Research Organisation
  • Compass3D
  • Cornell University
  • CPA Group
  • CTI Renato Archer
  • Dante Pazzanese Cardiology Institute
  • Deakin University
  • Deloitte Consulting
  • Dentca
  • DePuy Synthes
  • Deutsches Herzzentrum Berlin
  • DiSanto Technology
  • Drexel University
  • Emerging Implant Technologies
  • EnvisionTEC
  • EOS
  • Epson
  • Erasmus Medical Center
  • ETH Zurich
  • European Commission
  • European Medicines Agency
  • Eyedrivomatic
  • FDA Centre for Devices and Radiological Health
  • Federal Aviation Administration
  • FirstSurface
  • Focus Economics
  • Food and Drug Administration
  • Food and Drug Administration Centre for Devices and Radiological Health
  • Formlabs
  • Fraunhofer Institutes
  • Fripp Design and Research
  • Fundamentals of Robotic Gynecologic Surgery
  • Geomagic
  • GrabCAD
  • Great Ormond Street Hospital for Children
  • Grid Logic Incorporated
  • Harvard University
  • Harvest Technologies
  • Hewlett-Packard
  • Howard Hughes Medical Institute
  • iBox Printers
  • Imaginarium
  • Indiegogo
  • Industry Alliance of China 3D Printing Technology
  • Innovate UK
  • Interfacial Solutions
  • Intuitive Surgical
  • Invetech
  • Italian Digital Biomanufacturing Network
  • Janssen Research and Development
  • Johnson & Johnson
  • Joimax
  • Journal of Biomedical Materials Research
  • Kyoto University Graduate School of Medicine
  • Knight Cancer Institute of Oregon Health and Science University
  • Lab 22
  • Laser Zentrum Hannover
  • LayerWise
  • Lima Corporate
  • Lincsolution
  • Leapfrog
  • Leiden University
  • Lockheed Martin
  • L'Oreal
  • Maastricht Instruments B.V.
  • MakerBot
  • Manchester Metropolitan University
  • Massachusetts Institute of Technology
  • Materialise NV
  • Mattel Children's Hospital
  • Mayo Clinic
  • MCP HEK Tooling
  • Medical Modeling Inc.
  • Medicines and Healthcare Regulatory Agency
  • Merck & Co.
  • Michael J Fox Foundation
  • Michigan Technological University
  • Ministry of Industry and Information Technology
  • MirrorMe3D
  • Mobelife
  • MobileODT
  • MTU Aero Engines
  • Nakashima Medical
  • Nano 3D Biosciences
  • Nanyang Technological University
  • NASA
  • National Engineering Research Centre of Rapid Manufacturing
  • National Institute of Health
  • National Institute of Health 3D Print Exchange
  • National Kidney Foundation
  • National Additive Manufacturing Innovation Institute
  • Next 21
  • NHS
  • North Carolina State University
  • Northrop Grumman
  • NYU Langone Medical Center
  • OBL
  • Optomec
  • Organovo
  • Organisation for Economic Co-operation and Development (OECD)
  • Osteopore International
  • Oxford Performance Materials
  • Paramount Industries
  • Peking University 3rd Hospital
  • Pfizer
  • Proto Labs
  • Protosys Technologies
  • Queen's Medical Centre
  • Rainbow BioSciences
  • Rainbow Coral Corp.
  • RedEye
  • RegenHU
  • Renishaw
  • Replica 3dm
  • REVOLUTION Medicines
  • Revotek
  • Rice University
  • Roche
  • Rokit
  • Royal Perth Hospital
  • Salamanca University Hospital
  • Salisbury District Hospital
  • Siemens Corporation
  • Simbionix
  • Singapore Centre for 3D Printing
  • SIU System
  • Sixense
  • Smith & Nephew
  • Solid Concepts
  • South Korean Ministry of Trade, Industry and Energy
  • South Korean Ministry of Science, ICT and Future Planning
  • Southampton General Hospital
  • State Food and Drug Administration
  • Stratasys
  • Stryker
  • Technology Strategy Board
  • Teijin Nakashima Medical
  • TeVido Biodevices
  • Texas A&M University
  • Texas Tech University
  • The Cronin Group
  • TinkerCAD
  • Tissue Regeneration Systems
  • Toshiba
  • Tronrud
  • Tsingua University
  • TU Berlin
  • UCL School of Pharmacy
  • Ultimaker
  • UniQuest
  • United Therapeutics
  • University College London
  • University of California
  • University of Central Lancashire
  • University of Glasgow
  • University of Groningen
  • University of Iowa
  • University of Michigan
  • University of North Carolina
  • University of Northern Iowa
  • University of Nottingham
  • University of Pennsylvania
  • University of Queensland
  • University of Saskatchewan
  • University of Sheffield
  • University of Wisconsin
  • University of Texas at El Paso
  • U.S. Army
  • U.S. Department of Health and Human Services
  • Venture Investors
  • Vidar Systems Corp.
  • VIVOS Dental
  • Wake Forest Institute for Regenerative Medicine (WFIRM)
  • Walter Reed National Military Medical Centre
  • Weill Cornell Medical College
  • Wellcome Trust
  • Wohlers Associates
  • World Health Organization (WHO)
  • World Intellectual Property Organisation
  • Wyss Institute at Harvard University
  • Xilloc Medical
  • Zdravprint
  • Zimmer Biomet
Back to Top